TY - EJOUR
AU - Wang, Yingying
AU - Dai, Shasha
AU - Yang, Jing
AU - Ma, Jun
AU - Wang, Peng
AU - Zhao, Xiaowei
AU - Liu, Juan
AU - Xiao, Ao
AU - Song, Yahui
AU - Gao, Lipin
PY - 2023
DA - November
TI - Effect of metformin treatment on multiple cytokines and oxidative stress in type 2 diabetes mellitus patients
T2 - International Journal of Industrial Chemistry
VL - 13
L1 - https://oiccpress.com/international-journal-of-industrial-chemistry/article/effect-of-metformin-treatment-on-multiple-cytokines-and-oxidative-stress-in-type-2-diabetes-mellitus-patients/
N2 - Objective: To investigate the effect of metformin treatment on multiple cytokines and oxidative stress in type 2 diabetes mellitus (T2DM) patients. Methods: The 130 newly diagnosed T2DM patients were randomly divided into an observation group and a control group, with 40 cases in each group. The patients in the control group was treated conventionally, and the patients in the observation group was given 500 mg of metformin twice a day after meals for 3 months. The ankle-brachial index, oxidative stress index level, inflammatory cytokine level, pain degree (VAS score), clinical symptom scores and treatment effect were compared between the two groups before and after treatment. Results: The results showed that the clinical symptom scores were significantly lower, and the ABI index was significantly higher in the observation group after treatment than those in the control group and before treatment (P < 0.05). The levels of isoprostaglandin F2α and oxidized low-density lipoprotein were lower and the superoxide dismutase level was higher in the observation group after treatment than those in the control group and before treatment (P < 0.05). After treatment, the pain degree score in the observation group was lower than that in the control group (P < 0.05). The total effective rate in the observation group was 97.50%, which was higher than the 72.50% in the control group. Conclusion: Metformin treatment can significantly improve the clinical symptoms of T2DM patients and sufficiently reduce the level of oxidative stress, while has no significant effect on the inflammatory cytokines in patients.
IS - 2
PB - OICC Press
KW - Metformin, Inflammatory cytokines, Oxidative stress, Type 2 diabetes mellitus 
EN -